Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma.

[1]  C. Cooper,et al.  Management of male osteoporosis: report of the UK Consensus Group. , 1998, QJM : monthly journal of the Association of Physicians.

[2]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[3]  P. Ryan.  Overview of role of BMD measurements in managing osteoporosis. , 1997, Seminars in nuclear medicine.

[4]  S. Graham,et al.  Bone fractures associated with luteinizing hormone‐releasing hormone agonists used in the treatment of prostate carcinoma , 1997, Cancer.

[5]  J. Sibilia,et al.  Gonadotrophin-releasing hormone agonists induce osteoporosis. , 1994, British journal of rheumatology.

[6]  K. Khaw,et al.  Sex hormones and bone mineral density in elderly men. , 1993, Bone and mineral.

[7]  Y. Weisman,et al.  Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). , 1993, The Journal of clinical endocrinology and metabolism.

[8]  C. Nilsson,et al.  Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. , 1990, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  D. Baylink,et al.  Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. , 1989, The Journal of clinical endocrinology and metabolism.

[10]  R. Ziegler,et al.  Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma. , 1989, Human reproduction.

[11]  W. Crowley,et al.  Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. , 1988, The Journal of clinical endocrinology and metabolism.

[12]  R M Neer,et al.  Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism. , 1986, JAMA.

[13]  A. Klibanski,et al.  Osteoporosis in men with hyperprolactinemic hypogonadism. , 1986, Annals of internal medicine.

[14]  I. Fraser.  Relationship between gonadotrophin-releasing hormone analogue therapy and bone loss; a review. , 1991, Reproduction, fertility, and development.